https://m2.mtmt.hu/hun2024-03-28 14:24BookChapter26107062APPROVEDVALIDATION_ERRORtrue02016-10-04T10:20:56.000+0000false161070622023-05-05T11:56:59.053+00002021-03-02T14:14:32.986+00002016-10-03T12:41:06.000+0000true10023881Börcsökné EndreffyEmőke
/api/author/10023881
Authortrue100238812021-03-02T14:14:34.128+00002021-03-02T14:14:34.128+0000falsefalsetrue2525
/api/publicationtype/25
PublicationType2true25BookChaptertrue10000398Chaptertrue2525
/api/publicationtype/25
PublicationType2true25BookChapter
/api/subtype/10000398
KönyvfejezetSubType220true10000398true1
/api/category/1
Categorytrue1Brodsky, SVAcute and chronic tubulointerstitial nephritis20142016(Börcsökné Endreffy Emőke (Klinikai molekuláris ge...); 2016.10.03. 14:40:34)truetruetruefalsefalseNONE2023-05-05false00000000000022Councilman, W., Acute interstitial nephritis (1898) J Exp Med, 3, pp. 393-390;
Rastegar, A., Kashgarian, M., The clinical spectrum of tubulointerstitial nephritis (1898) Kidney Int, 54 (2), pp. 313-327;
Praga, M., González, E., Acute interstitial nephritis (2010) Kidney Int, 77 (11), pp. 956-961;
Ulinski, T., Sellier-Leclerc, A.L., Tudorache, E., Acute tubulointerstitial nephritis (2012) Pediatr Nephrol, 27 (7), pp. 1051-1057;
Mezzano, S., Droguett, A., Burgos, M.E., Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy (2003) Kidney Int Suppl, (86), pp. S64-S70;
Churg, J., Cotran, R., Sinniah, R., (1985) Renal Disease: Classification and Atlas of Tubulointerstitial Diseases, , Tokyo, Japan: Igaku-Shoin;
Colvin, R., Fang, L., Interstitial nephritis (1994) Renal Pathology with Clinical and Functional Correlations, p. 723. , Tisher C, Brenner B, eds, Vol 1. Philadelphia: JB Lippincott;
Baker, R.J., Pusey, C.D., The changing profile of acute tubulointerstitial nephritis (2004) Nephrol Dial Transplant, 19 (1), pp. 8-11;
Schwarz, A., Krause, P.H., Kunzendorf, U., The outcome of acute interstitial nephritis: Risk factors for the transition from acute to chronic interstitial nephritis (2000) Clin Nephrol, 54 (3), pp. 179-190;
Perazella, M.A., Markowitz, G.S., Drug-induced acute interstitial nephritis (2010) Nat Rev Nephrol, 6 (8), pp. 461-470;
Distler, A., Keller, F., Kunzendorf, U., The outcome of acute interstitial nephritis: risk factors for the transition from acute to chronic interstitial nephritis (2003) Clin Nephrol, 59, p. 65;
Buysen, J.G., Houthoff, H.J., Krediet, R.T., Acute interstitial nephritis: a clinical and morphological study in 27 patients (1890) Nephrol Dial Transplant, 5, pp. 94-99;
Raissian, Y., Nasr, S.H., Larsen, C.P., Diagnosis of IgG4-related tubulointerstitial nephritis (2011) J Am Soc Nephrol, 22 (7), pp. 1343-1352;
Fletcher, A., Eosinophiluria and acute interstitial nephritis (2008) N Engl J Med, 358 (16), pp. 1760-1761;
Ruffing, K.A., Hoppes, P., Blend, D., Eosinophils in urine revisited (1894) Clin Nephrol, 41, pp. 163-166;
Bender, W.L., Whelton, A., Beschorner, W.E., Interstitial nephritis, proteinuria, and renal failure caused by nonsteroidal anti-inflammatory drugs. Immunologic characterization of the inflammatory infiltrate (1884) Am J Med, 76, pp. 1006-1012;
Spanou, Z., Keller, M., Britschgi, M., Involvement of drug-specific T cells in acute drug-induced interstitial nephritis (2006) J Am Soc Nephrol, 17 (10), pp. 2919-2927;
D'Agati, V.D., Appel, G.B., Estes, D., Monoclonal antibody identification of infiltrating mononuclear leukocytes in lupus nephritis (1886) Kidney Int, 30, pp. 573-581;
Zheng, G., Wang, Y., Mahajan, D., The role of tubulointerstitial inflammation (2005) Kidney Int Suppl, 94, pp. S96-S100;
Sean Eardley, K., Cockwell, P., Macrophages and progressive tubulointerstitial disease (2005) Kidney Int, 68 (2), pp. 437-455;
Hawkins, E.P., Berry, P.L., Silva, F.G., Acute tubulointerstitial nephritis in children: clinical, morphologic, and lectin studies. A report of the southwest pediatric nephrology study group (1889) Am J Kidney Dis, 14, pp. 466-471;
Ivanyi, B., Marcussen, N., Kemp, E., The distal nephron is preferentially infiltrated by inflammatory cells in acute interstitial nephritis (1892) Virchows Arch A Pathol Anat Histopathol, 420, pp. 37-42;
Satoskar, A.A., Brodsky, S.V., Nadasdy, G., Discrepancies in glomerular and tubulointerstitial/vascular immune complex IgG subclasses in lupus nephritis (2011) Lupus, 20 (13), pp. 1396-1403;
Bijol, V., Mendez, G.P., Nosé, V., Granulomatous interstitial nephritis: a clinicopathologic study of 46 cases from a single institution (2006) Int J Surg Pathol, 14 (1), pp. 57-63;
Robson, M.G., Banerjee, D., Hopster, D., Seven cases of granulomatous interstitial nephritis in the absence of extrarenal sarcoid (2003) Nephrol Dial Transplant, 18, pp. 280-284;
Joss, N., Morris, S., Young, B., Granulomatous interstitial nephritis (2007) Clin J Am Soc Nephrol, 2 (2), pp. 222-230;
Nadasdy, T., Laszik, Z., Blick, K.E., Tubular atrophy in the end-stage kidney: a lectin and immunohistochemical study (1894) Hum Pathol, 25, pp. 22-28;
Brodsky, S.V., Albawardi, A., Satoskar, A.A., When one plus one equals more than two-a novel stain for renal biopsies is a combination of two classical stains (2010) Histol Histopathol, 25 (11), pp. 1379-1383;
Pfaller, W., Rittinger, M., Quantitative morphology of the rat kidney (1880) Int J Biochem, 12, pp. 17-22;
Knepper, M.A., Danielson, R.A., Saidel, G.M., Quantitative analysis of renal medullary anatomy in rats and rabbits (1877) Kidney Int, 12, pp. 313-323;
Zeisberg, M., Neilson, E.G., Mechanisms of tubulointerstitial fibrosis (2010) J Am Soc Nephrol, 21 (11), pp. 1819-1834;
Silva, F.G., Nadasdy, T., Laszik, Z., Immunohistochemical and lectin dissection of the human nephron in health and disease (1893) Arch Pathol Lab Med, 117, pp. 1233-1239;
Takemura, Y., Koshimichi, M., Sugimoto, K., A tubulointerstitial nephritis antigen gene defect causes childhood-onset chronic renal failure (2010) Pediatr Nephrol, 25 (7), pp. 1349-1353;
Jenkins, J., Brodsky, S.V., Satoskar, A.A., The relevance of periglomerular fibrosis in the evaluation of routine core renal biopsies (2011) Arch Pathol Lab Medication, 135, pp. 117-122;
Isbel, N.M., Hill, P.A., Foti, R., Tubules are the major site of M-CSF production in experimental kidney disease: Correlation with local macrophage proliferation (2001) Kidney Int, 60, pp. 614-625;
Rovin, B.H., Beyond a glomerulocentric view of inflammation (2001) Kidney Int, 60, pp. 797-798;
McAdam, A.J., Sharpe, A.H., Infectious diseases (2009) Robbins & Cotran Pathologic Basis of Disease, 8th ed, p. 331. , Kumar V, Abbas AK, Fausto N, Aster JC, eds, Philadelphia: WB Saunders Elsevier;
Rossert, J., Drug-induced acute interstitial nephritis (2001) Kidney Int, 60, pp. 804-817;
Ikeda, M., Takemura, T., Hino, S., Molecular cloning, expression, and chromosomal localization of a human tubulointerstitial nephritis antigen (2000) Biochem Biophys Res Commun, 268 (1), pp. 225-230;
Serafini-Cessi, F., Malagolini, N., Cavallone, D., Tamm-Horsfall glycoprotein: Biology and clinical relevance (2003) Am J Kidney Dis, 42 (4), pp. 658-676;
Stone, J.H., Zen, Y., Deshpande, V., IgG4-related disease (2012) N Engl J Med, 366 (6), pp. 539-551;
Kambham, N., Markowitz, G.S., Tanji, N., Idiopathic hypocomplementemic interstitial nephritis with extensive tubulointerstitial deposits (2001) Am J Kidney Dis, 37, pp. 388-399;
Wada, T., Furuichi, K., Sakai, N., Eotaxin contributes to renal interstitial eosinophilia (1999) Nephrol Dial Transplant, 14, pp. 76-80;
Boor, P., Ostendorf, T., Floege, J., Renal fibrosis: Novel insights into mechanisms and therapeutic targets (2010) Nat Rev Nephrol, 6 (11), pp. 643-656;
Sato, M., Muragaki, Y., Saika, S., Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction (2003) J Clin Invest, 112, pp. 1486-1494;
Bottinger, E.P., Bitzer, M., TGF-beta signaling in renal disease (2002) J Am Soc Nephrol, 13, pp. 2600-2610;
August, P., Suthanthiran, M., Transforming growth factor beta and progression of renal disease (2003) Kidney Int Suppl, (87), pp. S99-S104;
Okada, H., Kikuta, T., Kobayashi, T., Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis (2005) J Am Soc Nephrol, 16, pp. 133-143;
Lan, H.Y., Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells (2003) Curr Opin Nephrol Hypertens, 12, pp. 25-29;
García-Sánchez, O., López-Hernández, F.J., López-Novoa, J.M., An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease (2010) Kidney Int, 77 (11), pp. 950-955;
Kriz, W., Kaissling, B., Le Hir, M., Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? (2011) J Clin Invest, 121 (2), pp. 468-474;
Humphreys, B.D., Lin, S.L., Kobayashi, A., Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis (2010) Am J Pathol, 176 (1), pp. 85-97;
Silva, F.G., Chemical-induced nephropathy: a review of the renal tubulointerstitial lesions in humans (2004) Toxicol Pathol, 32, pp. 71-84;
Markowitz, G.S., Perazella, M.A., Drug-induced renal failure: A focus on tubulointerstitial disease (2005) Clin Chim Acta, 351, pp. 31-47;
Ra, A., Tobe, S.W., Acute interstitial nephritis due to pantoprazole (2004) Ann Pharmacother, 38 (1), pp. 41-45;
Galpin, J.E., Shinaberger, J.H., Stanley, T.M., Acute interstitial nephritis due to methicillin (1978) Am J Med, 65, pp. 756-765;
Lieske, J.C., Bonebrake, D., Thesing, J., Eosinophiluria is common among patients after ileal conduit surgery (2011) Clin Chem Lab Med, 49 (11), pp. 1869-1871;
Lino, M., Binaut, R., Noël, L.H., Tubulointerstitial nephritis and Fanconi syndrome in primary biliary cirrhosis (2005) Am J Kidney Dis, 46 (3), pp. e41-e46;
Colvin, R.B., Burton, J.R., Hyslop, N.E., Jr., Letter: Penicillin-associated interstitial nephritis (1974) Ann Intern Med, 81, pp. 404-405;
Kondo, S., Kagami, S., Kido, H., Role of mast cell tryptase in renal interstitial fibrosis (2001) J Am Soc Nephrol, 12 (8), pp. 1668-1676;
Baldwin, D.S., Levine, B.B., McCluskey, R.T., Renal failure and interstitial nephritis due to penicillin and methicillin (1968) N Engl J Med, 279, pp. 1245-1252;
Border, W.A., Lehman, D.H., Egan, J.D., Antitubular basement-membrane antibodies in methicillin-associated interstitial nephritis (1974) N Engl J Med, 291, pp. 381-384;
Olsen, S., Asklund, M., Interstitial nephritis with acute renal failure following cardiac surgery and treatment with methicillin (1976) Acta Med Scand, 199, pp. 305-310;
Gabow, P.A., Lacher, J.W., Neff, T.A., Tubulointerstitial and glomerular nephritis associated with rifampin. Report of a case (1976) JAMA, 235, pp. 2517-2518;
Minetti, L., Barbiano di Belgioioso, G., Busnach, G., Immunohistological diagnosis of drug-induced hypersensitivity nephritis (1978) Contrib Nephrol, 10, pp. 15-29;
Olsen, T.S., Wassef, N.F., Olsen, H.S., Ultrastructure of the kidney in acute interstitial nephritis (1986) Ultrastruct Pathol, 10, pp. 1-16;
Dixit, M.P., Nguyen, C., Carson, T., Non-steroidal anti-inflammatory drugs-associated acute interstitial nephritis with granular tubular basement membrane deposits (2008) Pediatr Nephrol, 23 (1), pp. 145-148;
Vlasveld, L.T., van de Wiel-van Kemenade, E., Possible role for cytotoxic lymphocytes in the pathogenesis of acute interstitial nephritis after recombinant interleukin-2 treatment for renal cell cancer (1993) Cancer Immunol Immunother, 36, pp. 210-213;
Choi, Y.J., Chakraborty, S., Nguyen, V., Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: Altered expression of vascular endothelial growth factor (2000) Hum Pathol, 31, pp. 1491-1497;
Schwarz, A., Krause, P., Kunzendorf, U., The outcome of acute interstitial nephritis: Risk factors for the transition from acute to chronic interstitial nephritis (2003) Clin Nephrol, 59, p. 65;
Benner, E.J., Renal damage associated with prolonged administration of ampicillin, cephaloridine, and cephalothin (1969) Antimicrobial Agents Chemother, 9, pp. 417-420;
Burton, J.R., Lichtenstein, N.S., Colvin, R.B., Acute renal failure during cephalothin therapy (1974) JAMA, 229 (6), pp. 679-682;
Foord, R.D., Cephaloridine, cephalothin and the kidney (1975) J Antimicrob Chemother, 1, pp. 119-133;
Plakogiannis, R., Nogid, A., Acute interstitial nephritis associated with coadministration of vancomycin and ceftriaxone: Case series and review of the literature (2007) Pharmacotherapy, 27 (10), pp. 1456-1461;
Norrby, R., Stenqvist, K., Elgefors, B., Interaction between cephaloridine and furosemide in man (1976) Scand J Infect Dis, 8, pp. 209-212;
Fillastre, J.P., Kleinknecht, D., Acute renal failure associated with cephalosporin therapy (1975) Am Heart J, 89, pp. 809-810;
Wade, J.C., Smith, C.R., Petty, B.G., Cephalothin plus an aminoglycoside is more nephrotoxic than methicillin plus an aminoglycoside (1978) Lancet, 2, pp. 604-606;
Dodds, M.G., Foord, R.D., Enhancement by potent diuretics of renal tubular necrosis induced by cephaloridine (1970) Br J Pharmacol, 40, pp. 227-236;
Verma, S., Kieff, E., Cephalexin-related nephropathy (1975) JAMA, 234, pp. 618-619;
Barza, M., The nephrotoxicity of cephalosporins: An overview (1978) J Infect Dis, 137, pp. S60-S73;
Mancini, S., Iacovoni, R., Fierimonte, V., Drug-induced interstitial nephritis. A case report (1994) Minerva Pediatr, 46, pp. 557-560;
Goddard, J.K., Janning, S.W., Gass, J.S., Cefuroxime-induced acute renal failure (1994) Pharmacotherapy, 14, pp. 488-491;
Perkins, R.L., Apicella, M.A., Lee, I.S., Cephaloridine and cephalothin: comparative studies of potential nephrotoxicity (1968) J Lab Clin Med, 71, pp. 75-84;
Tong, J.E., Howell, D.N., Foreman, J.W., Drug-induced granulomatous interstitial nephritis in a pediatric patient (2007) Pediatr Nephrol, 22 (2), pp. 306-309;
Tune, B.M., Hsu, C.Y., Toxicity of cephaloridine to carnitine transport and fatty acid metabolism in rabbit renal cortical mitochondria: Structure-activity relationships (1994) J Pharmacol Exp Ther, 270, pp. 873-880;
Lash, L.H., Tokarz, J.J., Woods, E.B., Renal cell type specificity of cephalosporin-induced cytotoxicity in suspensions of isolated proximal tubular and distal tubular cells (1994) Toxicology, 94, pp. 97-118;
Levine, B.B., Antigenicity and cross-reactivity of penicillins and cephalosporins (1973) J Infect Dis, 128, pp. S364-S366;
Zaigraykin, N., Kovalev, J., Elias, N., Levofloxacin-induced interstitial nephritis and vasculitis in an elderly woman (2006) Isr Med Assoc J, 8 (10), pp. 726-727;
Hadimeri, H., Almroth, G., Cederbrant, K., Allergic nephropathy associated with norfloxacin and ciprofloxacin therapy. Report of two cases and review of the literature (1997) Scand J Urol Nephrol, 31, pp. 481-485;
Okada, H., Watanabe, Y., Kotaki, S., An unusual form of crystal-forming chronic interstitial nephritis following long-term exposure to tosufloxacin tosilate (2004) Am J Kidney Dis, 44, pp. 902-907;
Chatzikyrkou, C., Hamwi, I., Clajus, C., Biopsy proven acute interstitial nephritis after treatment with moxifloxacin (2010) BMC Nephrol, 11, p. 19;
Allon, M., Lopez, E.J., Min, K.W., Acute renal failure due to ciprofloxacin (1990) Arch Intern Med, 150, pp. 2187-2189;
Helmink, R., Benediktsson, H., Ciprofloxacin-induced allergic interstitial nephritis (1990) Nephron, 55, pp. 432-433;
Hootkins, R., Fenves, A.Z., Stephens, M.K., Acute renal failure secondary to oral ciprofloxacin therapy: A presentation of three cases and a review of the literature (1989) Clin Nephrol, 32, pp. 75-78;
Rastogi, S., Atkinson, J.L., McCarthy, J.T., Allergic nephropathy associated with ciprofloxacin (1990) Mayo Clin Proc, 65, pp. 987-989;
Shih, D.J., Korbet, S.M., Rydel, J.J., Renal vasculitis associated with ciprofloxacin (1995) Am J Kidney Dis, 26, pp. 516-519;
Lo, W.K., Rolston, K.V., Rubenstein, E.B., Ciprofloxacin-induced nephrotoxicity in patients with cancer (1993) Arch Intern Med, 153, pp. 1258-1262;
Lien, Y.H., Hansen, R., Kern, W.F., Ciprofloxacin-induced granulomatous interstitial nephritis and localized elastolysis (1993) Am J Kidney Dis, 22, pp. 598-602;
Garcia-Ortiz, R., Espinoza, R.S., Silva, G.R., Cloxacillin-induced acute tubulo interstitial nephritis (1992) Ann Pharmacother, 26, pp. 1241-1242;
Soto, J., Bosch, J.M., Alsar Ortiz, M.J., Piperacillin-induced acute interstitial nephritis (1993) Nephron, 65, pp. 154-155;
Pill, M.W., O'Neill, C.V., Chapman, M.M., Suspected acute interstitial nephritis induced by piperacillin-tazobactam (1997) Pharmacotherapy, 17, pp. 166-169;
Gilbert, D.N., Gourley, R., d'Agostino, A., Interstitial nephritis due to methicillin, penicillin and ampicillin (1970) Ann Allergy, 28, pp. 378-385;
Ruley, E.J., Lisi, L.M., Interstitial nephritis and renal failure due to ampicillin (1974) J Pediatr, 84, pp. 878-882;
Tannenberg, A.M., Wicher, K.J., Rose, N.R., Ampicillin nephropathy (1971) JAMA, 218, p. 449;
Woodroffe, A.J., Weldon, M., Meadows, R., Acute interstitial nephritis following ampicillin hypersensitivity (1975) Med J Aust, 1, pp. 65-68;
Ditlove, J., Weidmann, P., Bernstein, M., Methicillin nephritis (1977) Medicine (Baltimore), 56, pp. 483-491;
Jensen, H.A., Halveg, A.B., Saunamaki, K.I., Permanent impairment of renal function after methicillin nephropathy (1971) Br Med J, 4, p. 406;
Appel, G.B., Neu, H.C., The nephrotoxicity of antimicrobial agents (first of three parts) (1977) N Engl J Med, 296, pp. 663-670;
Mayaud, C., Kanfer, A., Kourilsky, O., Letter: Interstitial nephritis after methicillin (1975) N Engl J Med, 292, pp. 1132-1133;
Minetti, L., di Belgiojoso, G.B., Civati, G., Drug induced hypersensitivity nephritis (1975) Proc Eur Dial Transplant Assoc, 11, pp. 526-533;
Hansen, E.S., Tauris, P., Methicillin-induced nephropathy. A case with linear deposition of IgG and C3 on the tubular-basement-membrane (1976) Acta Pathol Microbiol Scand [A], 84, pp. 440-442;
Orfila, C., Rakotoarivony, J., Durand, D., A correlative study of immunofluorescence, electron, and light microscopy in immunologically mediated renal tubular disease in man (1979) Nephron, 23, pp. 14-22;
Rennke, H.G., Roos, P.C., Wall, S.G., Drug-induced interstitial nephritis with heavy glomerular proteinuria (1980) N Engl J Med, 302, pp. 691-692;
Pirani, C.L., Valeri, A., D'Agati, V., Renal toxicity of nonsteroidal anti-inflammatory drugs (1987) Contrib Nephrol, 55, pp. 159-175;
Flynn, C.T., Rainford, D.J., Hope, E., Acute renal failure and rifampicin: danger of unsuspected intermittent dosage (1974) Br Med J, 2, p. 482;
Muthukumar, T., Jayakumar, M., Fernando, E.M., Acute renal failure due to rifampicin: A study of 25 patients (2002) Am J Kidney Dis, 40, pp. 690-696;
Campese, V.M., Marzullo, F., Schena, F.P., Acute renal failure during intermittent rifampicin therapy (1973) Nephron, 10, pp. 256-261;
Ramgopal, V., Leonard, C., Bhathena, D., Acute renal failure associated with rifampicin (1973) Lancet, 1, pp. 1195-1196;
Schubert, C., Bates, W.D., Moosa, M.R., Acute tubulointerstitial nephritis related to antituberculous drug therapy (2010) Clin Nephrol, 73 (6), pp. 413-419;
Cochran, M., Morrhead, P.J., Platts, M., Letter: Permanent renal damage with rifampicin (1975) Lancet, 1, p. 1428;
Quinn, B.P., Wall, B.M., Nephrogenic diabetes insipidus and tubulointerstitial nephritis during continuous therapy with rifampin (1989) Am J Kidney Dis, 14, pp. 217-220;
Minetti, L., Barbiano di Belgioioso, G., Civati, G., Nephritis caused by drug hypersensitivity [DHN]. Clinico-histological observations in 15 cases (1974) Minerva Nefrol, 21, pp. 197-212;
Poole, G., Stradling, P., Worlledge, S., Potentially serious side effects of high-dose twice-weekly rifampicin (1971) Br Med J, 3, pp. 343-347;
Tomonaga, H., Detection of antibody specific to rifampicin metabolite by ELISA-mechanism of sensitization by rifampicin (1993) Arerugi, 42, pp. 854-863;
French, A., Hypersensitivity in the pathogenesis of the histopathologic changes associated with sulfonamide chemotherapy (1946) Am J Pathol, 22, p. 679;
More, R., McMillan, G., Duff, G., The pathology of sulfonamide allergy in man (1946) Am J Pathol, 22, p. 703;
Dry, J., Leynadier, F., Herman, D., Letter: Sulfamethoxazole-trimethoprim combination (cotrimoxazole). Unusual immuno-allergic reaction (1975) Nouv Presse Med, 4, p. 36;
Robson, M., Levi, J., Dolberg, L., Acute tubulo-interstitial nephritis following sulfadiazine therapy (1970) Isr J Med Sci, 6, pp. 561-566;
Bailey, R.R., Little, P.J., Deterioration in renal function in association with co-trimoxazole therapy (1976) Med J Aust, 1, pp. 914 and 916;
Kalowski, S., Nanra, R.S., Mathew, T.H., Deterioration in renal function in association with co-trimoxazole therapy (1973) Lancet, 1, pp. 394-397;
Augusto, J.F., Sayegh, J., Simon, A., A case of sulphasalazine-induced DRESS syndrome with delayed acute interstitial nephritis (2009) Nephrol Dial Transplant, 24 (9), pp. 2940-2942;
Farina, L.A., Palou Redorta, J., Chechile Toniolo, G., Reversible acute renal failure due to sulfonamide-induced lithiasis in an AIDS patient (1995) Arch Esp Urol, 48, pp. 418-419;
Albala, D.M., Prien, E.L., Jr., Galal, H.A., Urolithiasis as a hazard of sulfonamide therapy (1994) J Endourol, 8, pp. 401-403;
Russinko, P.J., Agarwal, S., Choi, M.J., Obstructive nephropathy secondary to sulfasalazine calculi (2003) Urology, 62, p. 748;
Dowling, H., Lepper, M., Toxic reactions following therapy with sulfapyridine, sulfathiazole and sulfadiazine (1943) JAMA, 121, p. 1190;
Cryst, C., Hammar, S.P., Acute granulomatous interstitial nephritis due to co-trimoxazole (1988) Am J Nephrol, 8, pp. 483-488;
Htike, N.L., Santoro, J., Gilbert, B., Biopsy-proven vancomycin-associated interstitial nephritis and acute tubular necrosis (2012) Clin Exp Nephrol, 16 (2), pp. 320-324;
Salazar, M.N., Matthews, M., Posadas, A., Biopsy proven interstitial nephritis following treatment with vancomycin: A case report (2010) Conn Med, 74 (3), pp. 139-141;
Hong, S., Valderrama, E., Mattana, J., Vancomycin-induced acute granulomatous interstitial nephritis: Therapeutic options (2007) Am J Med Sci, 334 (4), pp. 296-300;
Cimino, M.A., Rotstein, C., Slaughter, R.L., Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy (1987) Am J Med, 83, pp. 1091-1097;
Rybak, M.J., Albrecht, L.M., Boike, S.C., Nephrotoxicity of vancomycin, alone and with an aminoglycoside (1990) J Antimicrob Chemother, 25, pp. 679-687;
Nahata, M.C., Lack of nephrotoxicity in pediatric patients receiving concurrent vancomycin and aminoglycoside therapy (1987) Chemotherapy, 33, pp. 302-304;
Hsu, S.I., Biopsy-proved acute tubulointerstitial nephritis and toxic epidermal necrolysis associated with vancomycin (2001) Pharmacotherapy, 21, pp. 1233-1239;
Shah-Khan, F., Scheetz, M.H., Ghossein, C., Biopsy-proven acute tubular necrosis due to vancomycin toxicity (2011) Int J Nephrol, 2011, p. 436856;
Wu, C.Y., Wang, J.S., Chiou, Y.H., Biopsy proven acute tubular necrosis associated with vancomycin in a child: case report and literature review (2007) Ren Fail, 29 (8), pp. 1059-1061;
Wicklow, B.A., Ogborn, M.R., Gibson, I.W., Biopsy-proven acute tubular necrosis in a child attributed to vancomycin intoxication (2006) Pediatr Nephrol, 21 (8), pp. 1194-1196;
Kwon, H.S., Chang, Y.S., Jeong, Y.Y., A case of hypersensitivity syndrome to both vancomycin and teicoplanin (2006) J Korean Med Sci, 21 (6), pp. 1108-1110;
Yano, Y., Hiraoka, A., Oguma, T., Enhancement of tobramycin binding to rat renal brush border membrane by vancomycin (1995) J Pharmacol Exp Ther, 274, pp. 695-699;
Harris, R.C., Cyclooxygenase-2 in the kidney (2000) J Am Soc Nephrol, 11, pp. 2387-2394;
Galli, G., Panzetta, G., Do non-steroidal anti-inflammatory drugs and COX-2 selective inhibitors have different renal effects? (2002) J Nephrol, 15, p. 480;
Mungan, M.U., Gurel, D., Canda, A.E., Expression of COX-2 in normal and pyelonephritic kidney, renal intraepithelial neoplasia, and renal cell carcinoma (2006) Eur Urol, 50 (1), pp. 92-97;
Rocha, J.L., Fernandez-Alonso, J., Acute tubulointerstitial nephritis associated with the selective COX-2 enzyme inhibitor, rofecoxib (2001) Lancet, 357, pp. 1946-1947;
Demke, D., Zhao, S., Arellano, F.M., Interstitial nephritis associated with celecoxib (2001) Lancet, 358, pp. 1726-1727;
Henao, J., Hisamuddin, I., Nzerue, C.M., Celecoxib-induced acute interstitial nephritis (2002) Am J Kidney Dis, 39, pp. 1313-1317;
Alper, A.B., Jr., Meleg-Smith, S., Krane, N.K., Nephrotic syndrome and interstitial nephritis associated with celecoxib (2002) Am J Kidney Dis, 40, pp. 1086-1090;
Brewster, U.C., Perazella, M.A., Acute tubulointerstitial nephritis associated with celecoxib (2004) Nephrol Dial Transplant, 19, pp. 1017-1018;
Szalat, A., Krasilnikov, I., Bloch, A., Acute renal failure and interstitial nephritis in a patient treated with rofecoxib: Case report and review of the literature (2004) Arthritis Rheum, 51, pp. 670-673;
Fletcher, J.T., Graf, N., Scarman, A., Nephrotoxicity with cyclooxygenase 2 inhibitor use in children (2006) Pediatr Nephrol, 21 (12), pp. 1893-1897;
Taber, S.S., Pasko, D.A., The epidemiology of drug-induced disorders: The kidney (2008) Expert Opin Drug Saf, 7 (6), pp. 679-690;
Whelton, A., Hamilton, C.W., Nonsteroidal anti-inflammatory drugs: Effects on kidney function (1991) J Clin Pharmacol, 31, pp. 588-598;
Whelton, A., Nephrotoxicity of nonsteroidal anti-inflammatory drugs: Physiologic foundations and clinical implications (1999) Am J Med, 106, pp. 13S-24S;
Murray, M.D., Brater, D.C., Adverse effects of nonsteroidal anti-inflammatory drugs on renal function (1990) Ann Intern Med, 112, pp. 559-560;
Kleinknecht, D., Landais, P., Goldfarb, B., Analgesic and non-steroidal anti-inflammatory drug-associated acute renal failure: A prospective collaborative study (1986) Clin Nephrol, 25, pp. 275-281;
Fox, D.A., Jick, H., Nonsteroidal anti-inflammatory drugs and renal disease (1984) JAMA, 251, pp. 1299-1300;
Bonney, S.L., Northington, R.S., Hedrich, D.A., Renal safety of two analgesics used over the counter: Ibuprofen and aspirin (1986) Clin Pharmacol Ther, 40, pp. 373-377;
Corwin, H.L., Bonventre, J.V., Renal insufficiency associated with nonsteroidal anti-inflammatory agents (1984) Am J Kidney Dis, 4, pp. 147-152;
Clive, D.M., Stoff, J.S., Renal syndromes associated with nonsteroidal antiinflammatory drugs (1984) N Engl J Med, 310, pp. 563-572;
Palmer, B.F., Henrich, W.L., Clinical acute renal failure with nonsteroidal anti-inflammatory drugs (1995) Semin Nephrol, 15, pp. 214-227;
Marasco, W.A., Gikas, P.W., Azziz-Baumgartner, R., Ibuprofen-associated renal dysfunction. Pathophysiologic mechanisms of acute renal failure, hyperkalemia, tubular necrosis, and proteinuria (1987) Arch Intern Med, 147, pp. 2107-2116;
Whelton, A., Stout, R.L., Spilman, P.S., Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure. A prospective, randomized, crossover comparison (1990) Ann Intern Med, 112, pp. 568-576;
Calvo-Alen, J., De Cos, M.A., Rodriguez-Valverde, V., Subclinical renal toxicity in rheumatic patients receiving long-term treatment with nonsteroidal antiinflammatory drugs (1994) J Rheumatol, 21, pp. 1742-1747;
Carmichael, J., Shankel, S.W., Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function (1985) Am J Med, 78, pp. 992-1000;
Kleinknecht, D., Interstitial nephritis, the nephrotic syndrome, and chronic renal failure secondary to nonsteroidal anti-inflammatory drugs (1995) Semin Nephrol, 15, pp. 228-235;
Warren, G.V., Korbet, S.M., Schwartz, M.M., Minimal change glomerulopathy associated with nonsteroidal antiinflammatory drugs (1989) Am J Kidney Dis, 13, pp. 127-130;
Lantz, B., Cochat, P., Bouchet, J.L., Short-term niflumic-acid-induced acute renal failure in children (1994) Nephrol Dial Transplant, 9, pp. 1234-1239;
Kaplan, B.S., Restaino, I., Raval, D.S., Renal failure in the neonate associated with in utero exposure to non-steroidal anti-inflammatory agents (1994) Pediatr Nephrol, 8, pp. 700-704;
van der Heijden, B.J., Carlus, C., Narcy, F., Persistent anuria, neonatal death, and renal microcystic lesions after prenatal exposure to indomethacin (1994) Am J Obstet Gynecol, 171, pp. 617-623;
Voyer, L.E., Drut, R., Mendez, J.H., Fetal renal maldevelopment with oligohydramnios following maternal use of piroxicam (1994) Pediatr Nephrol, 8, pp. 592-594;
Ciabattoni, G., Cinotti, G.A., Pierucci, A., Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin (1984) N Engl J Med, 310, pp. 279-283;
Gurwitz, J.H., Avorn, J., Ross-Degnan, D., Nonsteroidal anti-inflammatory drug-associated azotemia in the very old (1990) JAMA, 264, pp. 471-475;
Harirforoosh, S., Jamali, F., Renal adverse effects of nonsteroidal anti-inflammatory drugs (2009) Expert Opin Drug Saf, 8 (6), pp. 669-681;
Gentilini, P., Cirrhosis, renal function and NSAIDs (1993) J Hepatol, 19, pp. 200-203;
Ahmad, S.R., Kortepeter, C., Brinker, A., Renal failure associated with the use of celecoxib and rofecoxib (2002) Drug Saf, 25 (7), pp. 537-544;
Blantz, R.C., Acetaminophen: Acute and chronic effects on renal function (1996) Am J Kidney Dis, 28, pp. S3-S6;
D'Agati, V., Does aspirin cause acute or chronic renal failure in experimental animals and in humans? (1996) Am J Kidney Dis, 28, pp. S24-S29;
Fruchter, L.L., Alexopoulou, I., Lau, K.K., Acute interstitial nephritis with acetaminophen and alcohol intoxication (2011) Ital J Pediatr, 37, p. 17;
Jickling, G., Heino, A., Ahmed, S.N., Acetaminophen toxicity with concomitant use of carbamazepine (2009) Epileptic Disord, 11 (4), pp. 329-332;
Cheng, H.F., Nolasco, F., Cameron, J.S., HLA-DR display by renal tubular epithelium and phenotype of infiltrate in interstitial nephritis (1989) Nephrol Dial Transplant, 4, pp. 205-215;
Schwarz, A., Krause, P.H., Keller, F., Granulomatous interstitial nephritis after nonsteroidal anti-inflammatory drugs (1988) Am J Nephrol, 8, pp. 410-416;
Baisac, J., Henrich, W.L., Nephrotoxicity of nonsteroidal anti-inflammatory drugs (1994) Miner Electrolyte Metab, 20, pp. 187-192;
Markowitz, G.S., Falkowitz, D.C., Isom, R., Membranous glomerulopathy and acute interstitial nephritis following treatment with celecoxib (2003) Clin Nephrol, 59 (2), pp. 137-142;
Sekhon, I., Munjal, S., Croker, B., Johnson, R.J., Ejaz, A.A., Glomerular tip lesion associated with nonsteroidal anti-inflammatory drug-induced nephrotic syndrome (2005) Am J Kidney Dis, 46 (4), pp. e55-e58;
Schlondorff, D., Renal prostaglandin synthesis. Sites of production and specific actions of prostaglandins (1986) Am J Med, 81, pp. 1-11;
Anderson, R.J., Berl, T., McDonald, K.M., Prostaglandins: Effects on blood pressure, renal blood flow, sodium and water excretion (1976) Kidney Int, 10, pp. 205-215;
Zambraski, E.J., The effects of nonsteroidal anti-inflammatory drugs on renal function: Experimental studies in animals (1995) Semin Nephrol, 15, pp. 205-213;
Remuzzi, A., Remuzzi, G., The effects of nonsteroidal anti-inflammatory drugs on glomerular filtration of proteins and their therapeutic utility (1995) Semin Nephrol, 15, pp. 236-243;
Spuhler, O., Hu, Z., Chronic interstitial nephritis (1953) Z Klin Med, 151, pp. 1-50;
Elseviers, M.M., De Broe, M.E., A long-term prospective controlled study of analgesic abuse in Belgium (1995) Kidney Int, 48, pp. 1912-1919;
Elseviers, M.M., Waller, I., Nenoy, D., Evaluation of diagnostic criteria for analgesic nephropathy in patients with end-stage renal failure: results of the ANNE study. Analgesic nephropathy network of Europe (1995) Nephrol Dial Transplant, 10, pp. 808-814;
Perneger, T.V., Whelton, P.K., Klag, M.J., Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs (1994) N Engl J Med, 331, pp. 1675-1679;
Pommer, W., Bronder, E., Greiser, E., Regular analgesic intake and the risk of end-stage renal failure (1989) Am J Nephrol, 9, pp. 403-412;
Sandler, D.P., Smith, J.C., Weinberg, C.R., Analgesic use and chronic renal disease (1989) N Engl J Med, 320, pp. 1238-1243;
Henrich, W.L., Agodoa, L.E., Barrett, B., Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation (1996) Am J Kidney Dis, 27 (1), pp. 162-165;
Elseviers, M., De Broe, M., The implication of analgesic in human kidney disease (1993) Analgesic and NSAID-Induced Kidney Disease, p. 32. , Stewart J, ed, Oxford: Oxford University Press;
Gault, M.H., Wilson, D.R., Analgesic nephropathy in Canada: Clinical syndrome, management, and outcome (1978) Kidney Int, 13, pp. 58-63;
Kincaid-Smith, P., Analgesic nephropathy and the effect of non-steroidal anti-inflammatory drugs on the kidney (1990) Drugs and the Kidney, p. 1. , Catto G, ed, Dordrecht: Kluwer Academic;
Gonwa, T.A., Hamilton, R.W., Buckalew, V.M., Jr., Chronic renal failure and end-stage renal disease in northwest North Carolina. Importance of analgesic-associated nephropathy (1981) Arch Intern Med, 141, pp. 462-465;
Elseviers, M., De Broe, M., Epidemiology of analgesic nephropathy (1992) J Nephrol, 5, p. 94;
Schwarz, A., Preuschof, L., Zellner, D., Incidence of analgesic nephropathy in Berlin since 1983 (1999) Nephrol Dial Transplant, 14, pp. 109-112;
Michielsen, P., de Schepper, P., Trends of analgesic nephropathy in two high-endemic regions with different legislation (2001) J Am Soc Nephrol, 12, pp. 550-556;
Chang, S.H., Mathew, T.H., McDonald, S.P., Analgesic nephropathy and renal replacement therapy in Australia: trends, comorbidities and outcomes (2008) Clin J Am Soc Nephrol, 3 (3), pp. 768-776;
Lornoy, W., Becaus, I., Billiouw, J.M., Relationship between nonphenacetin combined analgesics and nephropathy (2001) Kidney Int, 59, pp. 2371-2372;
Feinstein, A.R., Heinemann, L.A., Curhan, G.C., Relationship between nonphenacetin combined analgesics and nephropathy: A review. Ad hoc committee of the international study group on analgesics and nephropathy (2000) Kidney Int, 58, pp. 2259-2264;
Mihatsch, M.J., Khanlari, B., Brunner, F.P., Obituary to analgesic nephropathy-an autopsy study (2006) Nephrol Dial Transplant, 21 (11), pp. 3139-3145;
Michielsen, P., Heinemann, L., Mihatsch, M., Non-phenacetin analgesics and analgesic nephropathy: Clinical assessment of high users from a case-control study (2009) Nephrol Dial Transplant, 24 (4), pp. 1253-1259;
Van der Woude, F.J., Heinemann, L.A., Graf, H., Analgesics use and ESRD in younger age: a case-control study (2007) BMC Nephrol, 8, p. 15;
De Broe, M., Elseviers, M., Over-the-counter analgesic use (2009) J Am Soc Nephrol, 20, pp. 2098-2103;
Kurth, T., Glynn, R.J., Walker, A.M., Analgesic use and change in kidney function in apparently healthy men (2003) Am J Kidney Dis, 42, pp. 234-244;
Schnuelle, P., Van Der Woude, F.J., Analgesics and renal disease in the postphenacetin era (2003) Am J Kidney Dis, 42, pp. 385-387;
Nanra, R., Functional defects in analgesic nephropathy (1993) Analgesic and NSAID-Induced Kidney Disease, p. 102. , Stewart J, ed, Oxford: Oxford University Press;
Griffin, M.D., Bergstralhn, E.J., Larson, T.S., Renal papillary necrosis-a sixteen-year clinical experience (1995) J Am Soc Nephrol, 6, pp. 248-256;
De Broe, M.E., Elseviers, M.M., Analgesic nephropathy (1998) N Engl J Med, 338, pp. 446-452;
Burry, A., Pathology of analgesic nephropathy: Australian experience (1978) Kidney Int, 13, pp. 34-40;
Mihatsch, M., Zollinger, H., The pathology of analgesic nephropathy (1993) Analgesic and NSAID-Induced Kidney Disease, p. 67. , Stewart J, ed, Oxford: Oxford University Press;
Berneis, K., Korteweg, E., Mihatsch, M.J., Characterization of the brown pigment of the mucosa of the urinary tract (1983) Virchows Arch A Pathol Anat Histopathol, 402, pp. 203-207;
Gloor, F., Capillary sclerosis of the urinary tract caused by abuse of an analgesic agent (phenacetin) (1982) Pathologe, 3, pp. 132-136;
Mihatsch, M.J., Hofer, H.O., Gudat, F., Capillary sclerosis of the urinary tract and analgesic nephropathy (1983) Clin Nephrol, 20, pp. 285-301;
Mihatsch, M.J., Torhorst, J., Steinmann, E., The morphologic diagnosis of analgesic (phenacetin) abuse (1979) Pathol Res Pract, 164, pp. 68-79;
Burry, A., The evolution of analgesic nephropathy (1967) Nephron, 5, p. 185;
Kincaid-Smith, P., Pathogenesis of the renal lesion associated with the abuse of analgesics (1967) Lancet, 1, pp. 859-862;
Zollinger, H., (1966) Niere und ableitende harnwege, , Berlin: Springer Verlag;
Kincaid-Smith, P., Saker, B.M., McKenzie, I.F., Lesions in the blood supply of the papilla in experimental analgesic nephropathy (1968) Med J Aust, 1, pp. 203-206;
Molland, E.A., Experimental renal papillary necrosis (1978) Kidney Int, 13, pp. 5-14;
Lagergren, C., Ljungqvist, A., The intrarenal arterial pattern in renal papillary necrosis. A micro-angiographic and histologic study (1962) Am J Pathol, 41, pp. 633-643;
Prescott, L.F., Analgesic nephropathy: A reassessment of the role of phenacetin and other analgesics (1982) Drugs, 23, pp. 75-149;
Duggin, G.G., Mechanisms in the development of analgesic nephropathy (1980) Kidney Int, 18, pp. 553-561;
Duggin, G.G., Combination analgesic-induced kidney disease: The Australian experience (1996) Am J Kidney Dis, 28, pp. S39-S47;
Moeckel, G.W., Zhang, L., Fogo, A.B., COX2 activity promotes organic osmolyte accumulation and adaptation of renal medullary interstitial cells to hypertonic stress (2003) J Biol Chem, 278, pp. 19352-19357;
Li, C., Liu, J., Saavedra, J.E., The nitric oxide donor, V-PYRRO/NO, protects against acetaminophen-induced nephrotoxicity in mice (2003) Toxicology, 189, pp. 173-180;
Ahmed, M.H., Ashton, N., Balment, R.J., Renal function in a rat model of analgesic nephropathy: Effect of chloroquine (2003) J Pharmacol Exp Ther, 305, pp. 123-130;
Goncalves, A.R., Fujihara, C.K., Mattar, A.L., Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: Strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory (2004) Am J Physiol Renal Physiol, 286, pp. F945-F954;
Schnellmann, R.G., Analgesic nephropathy in rodents (1998) J Toxicol Environ Health B Crit Rev, 1, pp. 81-90;
Arend, L.J., Springate, J.E., Interstitial nephritis from mesalazine: Case report and literature review (2004) Pediatr Nephrol, 19, pp. 550-553;
Agarwal, B.N., Cabebe, F.G., Hoffman, B.I., Diphenylhydantoin-induced acute renal failure (1977) Nephron, 18, pp. 249-251;
Hyman, L.R., Ballow, M., Knieser, M.R., Diphenylhydantoin interstitial nephritis. roles of cellular and humoral immunologic injury (1978) J Pediatr, 92, pp. 915-920;
Mihatsch, M.J., Knusli, C., Phenacetin abuse and malignant tumors. An autopsy study covering 25 years (1953-1977) (1982) Klin Wochenschr, 60, pp. 1339-1349;
Taylor, J., Carcinoma of the renal pelvis (1993) Analgesic and NSAID-Induced Kidney Disease, p. 211. , Stewart J, ed, Oxford: Oxford University Press;
McCredie, M., Analgesics as human carcinogens: clinical and epidemiological evidence (1993) Analgesic and NSAID-Induced Kidney Disease, p. 211. , Stewart J, ed, Oxford: Oxford University Press;
Chow, W.H., McLaughlin, J.K., Linet, M.S., Use of analgesics and risk of renal cell cancer (1994) Int J Cancer, 59, pp. 467-470;
Van Staa, T.P., Travis, S., Leufkens, H.G., 5-aminosalicylic acids and the risk of renal disease: a large British epidemiologic study (2004) Gastroenterology, 126 (7), pp. 1733-1739;
Ransford, R.A., Langman, M.J., Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the committee on safety of medicines (2002) Gut, 51, pp. 536-539;
Matson, J.R., Krous, H.F., Blackstock, R., Diphenylhydantoin-induced hypersensitivity reaction with interstitial nephritis (1985) Hum Pathol, 16, pp. 94-97;
Gaffey, C.M., Chun, B., Harvey, J.C., Phenytoin-induced systemic granulomatous vasculitis (1986) Arch Pathol Lab Med, 110, pp. 131-135;
Alexander, M.P., Farag, Y.M., Mittal, B.V., Lithium toxicity: A double-edged sword (2008) Kidney Int, 73 (2), pp. 233-237;
Presne, C., Fakhouri, F., Noel, L.H., Lithium-induced nephropathy: Rate of progression and prognostic factors (2003) Kidney Int, 64, pp. 585-592;
Hestbech, J., Hansen, H.E., Amdisen, A., Chronic renal lesions following long-term treatment with lithium (1977) Kidney Int, 12, pp. 205-213;
Cox, M., Lithium in the kidney (1981) Kidney Int, 19, p. 379;
Jorkasky, D.K., Amsterdam, J.D., Oler, J., Lithium-induced renal disease: A prospective study (1988) Clin Nephrol, 30, pp. 293-302;
Walker, R., Edwards, J., Lithium and the kidney: An update. [editorial] (1989) Psychol Med, 19, p. 825;
Markowitz, G.S., Radhakrishnan, J., Kambham, N., Lithium nephrotoxicity: A progressive combined glomerular and tubulointerstitial nephropathy (2000) J Am Soc Nephrol, 11, pp. 1439-1448;
Dias, N., Hocken, A.G., Oliguric renal failure complicating lithium carbonate therapy (1973) Nephron, 10, pp. 246-249;
Lavender, S., Brown, J.N., Berrill, W.T., Acute renal failure and lithium intoxication (1973) Postgrad Med J, 49, pp. 277-279;
Aurell, M., Svalander, C., Wallin, L., Renal function and biopsy findings in patients on long-term lithium treatment (1981) Kidney Int, 20, pp. 663-670;
Kincaid-Smith, P., Burrows, G.D., Davies, B.M., Renal-biopsy findings in lithium and prelithium patients (1979) Lancet, 2, pp. 700-701;
Walker, R.G., Bennett, W.M., Davies, B.M., Structural and functional effects of long-term lithium therapy (1982) Kidney Int Suppl, 11, pp. S13-S19;
Santella, R.N., Rimmer, J.M., MacPherson, B.R., Focal segmental glomerulosclerosis in patients receiving lithium carbonate (1988) Am J Med, 84, pp. 951-954;
Tam, V.K., Green, J., Schwieger, J., Nephrotic syndrome and renal insufficiency associated with lithium therapy (1996) Am J Kidney Dis, 27, pp. 715-720;
Christensen, B.M., Marples, D., Kim, Y.H., Changes in cellular composition of kidney collecting duct cells in rats with lithium-induced NDI (2004) Am J Physiol Cell Physiol, 286, pp. C952-C964;
Delve, P., Lau, M., Yun, K., Omeprazole-induced acute interstitial nephritis (2003) N Z Med J, 116, p. U332;
Moore, I., Sayer, J.A., Nayar, A., Pantoprazole-induced acute interstitial nephritis (2004) J Nephrol, 17, pp. 580-581;
Torpey, N., Barker, T., Ross, C., Drug-induced tubulo-interstitial nephritis secondary to proton pump inhibitors: Experience from a single UK renal unit (2004) Nephrol Dial Transplant, 19, pp. 1441-1446;
Geevasinga, N., Kairaitis, L., Rangan, G.K., Acute interstitial nephritis secondary to esomeprazole (2005) Med J Aust, 182, pp. 235-236;
Ray, S., Delaney, M., Muller, A.F., Proton pump inhibitors and acute interstitial nephritis (2010) BMJ, 341, p. c4412;
Myers, R.P., McLaughlin, K., Hollomby, D.J., Acute interstitial nephritis due to omeprazole (2001) Am J Gastroenterol, 96, pp. 3428-3431;
Kalyesubula, R., Perazella, M.A., Nephrotoxicity of HAART (2011) AIDS Res Treat, 2011, p. 562790. , [Epub 2011 Aug 15];
Sarcletti, M., Petter, A., Zangerle, R., Indinavir and interstitial nephritis (1998) Ann Intern Med, 128, pp. 320-321;
Olyaei, A.J., deMattos, A.M., Bennett, W.M., Renal toxicity of protease inhibitors (2000) Curr Opin Nephrol Hypertens, 9, pp. 473-476;
Jaradat, M., Phillips, C., Yum, M.N., Acute tubulointerstitial nephritis attributable to indinavir therapy (2000) Am J Kidney Dis, 35, p. E16;
Brewster, U.C., Perazella, M.A., Acute interstitial nephritis associated with atazanavir, a new protease inhibitor (2004) Am J Kidney Dis, 44, pp. e81-e84;
Schmid, S., Opravil, M., Moddel, M., Acute interstitial nephritis of HIV-positive patients under atazanavir and tenofovir therapy in a retrospective analysis of kidney biopsies (2007) Virchows Arch, 450 (6), pp. 665-670;
McCluskey, R., Immunologically mediated tubulo-interstitial nephritis (1983) Contemp Issues Nephrol, 10, p. 121;
Kelly, C., Tomaszewski, J., Neilson, E., Immunopathogenic mechanisms of tubulointerstitial injury (1994) Renal Pathology with Clinical and Functional Correlations, p. 699. , Tisher C, Brenner B, eds, Vol 1. Philadelphia: JB Lippincott;
Wuthrich, R.P., Sibalic, V., Autoimmune tubulointerstitial nephritis: Insight from experimental models (1998) Exp Nephrol, 6, pp. 288-293;
Miller, K., Michael, A.F., Immunopathology of renal extracellular membranes in diabetes mellitus. specificity of tubular basement-membrane immunofluorescence (1976) Diabetes, 25, pp. 701-708;
Lehman, D.H., Wilson, C.B., Dixon, F.J., Extraglomerular immunoglobulin deposits in human nephritis (1975) Am J Med, 58, pp. 765-796;
Clayman, M.D., Martinez-Hernandez, A., Michaud, L., Isolation and characterization of the nephritogenic antigen producing anti-tubular basement membrane disease (1985) J Exp Med, 161, pp. 290-305;
Brentjens, J.R., Matsuo, S., Fukatsu, A., Immunologic studies in two patients with antitubular basement membrane nephritis (1989) Am J Med, 86, pp. 603-608;
Nelson, T.R., Charonis, A.S., McIvor, R.S., Identification of a cDNA encoding tubulointerstitial nephritis antigen (1995) J Biol Chem, 270, pp. 16265-16270;
Xie, P., Kondeti, V.K., Lin, S., Role of extracellular matrix renal tubulo-interstitial nephritis antigen (TINag) in cell survival utilizing integrin (alpha)vbeta3/focal adhesion kinase (FAK)/phosphatidylinositol 3-kinase (PI3K)/protein kinase B-serine/threonine kinase (AKT) signaling pathway (2011) J Biol Chem, 286 (39), pp. 34131-34146;
Bergstein, J., Litman, N., Interstitial nephritis with anti-tubular-basement-membrane antibody (1975) N Engl J Med, 292, pp. 875-878;
Rakotoarivony, J., Orfila, C., Segonds, A., Human and experimental nephropathies associated with antibodies to tubular basement membrane (1981) Adv Nephrol Necker Hosp, 10, pp. 187-212;
Freycon, M.T., Gilly, J., Bouvier, R., Braye, A., Familial chronic tubulointerstitial nephritis with antibodies to the tubular basement membrane (1982) Pediatrie, 37, pp. 371-381;
Helczynski, L., Landing, B.H., Tubulointerstitial renal diseases of children: Pathologic features and pathogenetic mechanisms in Fanconi's familial nephronophthisis, antitubular basement membrane antibody disease, and medullary cyst disease (1984) Pediatr Pathol, 2, pp. 1-24;
Kalluri, R., Wilson, C.B., Weber, M., Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and goodpasture syndrome (1995) J Am Soc Nephrol, 6, pp. 1178-1185;
Andres, G., Brentjens, J., Kohli, R., Histology of human tubulo-interstitial nephritis associated with antibodies to renal basement membranes (1978) Kidney Int, 13, pp. 480-491;
Graindorge, P.P., Mahieu, P.R., Radioimmunologic method for detection of antitubular basement membrane antibodies (1978) Kidney Int, 14 (6), pp. 594-606;
Border, W.A., Baehler, R.W., Bhathena, D., IgA antibasement membrane nephritis with pulmonary hemorrhage (1979) Ann Intern Med, 91, pp. 21-25;
Levy, M., Guesry, P., Loirat, C., Immunologically mediated tubulo-interstitial nephritis in children (1979) Contrib Nephrol, 16, pp. 132-140;
Katz, A., Fish, A.J., Santamaria, P., Role of antibodies to tubulointerstitial nephritis antigen in human anti-tubular basement membrane nephritis associated with membranous nephropathy (1992) Am J Med, 93, pp. 691-698;
Makker, S., Widstrom, R., Huang, J., Characterization of glomerular antigen of membranous nephropathy (MN) in the syndrome of MN, tubulointerstitial nephritis (TN) and Fanconi syndrome (1995) J Am Soc Nephrol, 6, p. 925;
Tay, A.H., Ren, E.C., Murugasu, B., Membranous nephropathy with anti-tubular basement membrane antibody may be X-linked (2000) Pediatr Nephrol, 14, pp. 747-753;
Kerjaschki, D., Farquhar, M.G., Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats (1983) J Exp Med, 157, pp. 667-686;
Ivanyi, B., Haszon, I., Endreffy, E., Childhood membranous nephropathy, circulating antibodies to the 58-kD TIN antigen, and anti-tubular basement membrane nephritis: An 11-year follow-up (1998) Am J Kidney Dis, 32, pp. 1068-1074;
Rotellar, C., Noel, L.H., Droz, D., Role of antibodies directed against tubular basement membranes in human renal transplantation (1986) Am J Kidney Dis, 7, pp. 157-161;
Wilson, C.B., Lehman, D.H., McCoy, R.C., Antitubular basement membrane antibodies after renal transplantation (1974) Transplantation, 18, pp. 447-452;
Morel-Maroger, L., Kourilsky, O., Mignon, F., Antitubular basement membrane antibodies in rapidly progressive poststreptococcal glomerulonephritis: Report of a case (1974) Clin Immunol Immunopathol, 2, pp. 185-194;
Makker, S.P., Tubular basement membrane antibody-induced interstitial nephritis in systemic lupus erythematosus (1980) Am J Med, 69, pp. 949-952;
Clayman, M.D., Michaud, L., Brentjens, J., Isolation of the target antigen of human anti-tubular basement membrane antibody-associated interstitial nephritis (1986) J Clin Invest, 77, pp. 1143-1147;
Yoshioka, K., Morimoto, Y., Iseki, T., Characterization of tubular basement membrane antigens in human kidney (1986) J Immunol, 136, pp. 1654-1660;
Crary, G.S., Katz, A., Fish, A.J., Role of a basement membrane glycoprotein in anti-tubular basement membrane nephritis (1993) Kidney Int, 43, pp. 140-146;
Yoshioka, K., Hino, S., Takemura, T., Isolation and characterization of the tubular basement membrane antigen associated with human tubulo-interstitial nephritis (1992) Clin Exp Immunol, 90, pp. 319-325;
Miyazato, H., Yoshioka, K., Hino, S., The target antigen of anti-tubular basement membrane antibody-mediated interstitial nephritis (1994) Autoimmunity, 18, pp. 259-265;
Kalfa, T.A., Thull, J.D., Butkowski, R.J., Tubulointerstitial nephritis antigen interacts with laminin and type IV collagen and promotes cell adhesion (1994) J Biol Chem, 269, pp. 1654-1659;
Chen, Y., Krishnamurti, U., Wayner, E.A., Receptors in proximal tubular epithelial cells for tubulointerstitial nephritis antigen (1996) Kidney Int, 49, pp. 153-157;
Kanwar, Y.S., Kumar, A., Yang, Q., Tubulointerstitial nephritis antigen: an extracellular matrix protein that selectively regulates tubulogenesis vs. glomerulogenesis during mammalian renal development (1999) Proc Natl Acad Sci U S A, 96, pp. 11323-11328;
Yoshioka, K., Takemura, T., Hattori, S., Tubulointerstitial nephritis antigen: primary structure, expression and role in health and disease (2002) Nephron, 90, pp. 1-7;
Sugimoto, K., Takemura, Y., Yanagida, H., Renal tubular dysgenesis and tubulointerstitial nephritis antigen in juvenile nephronophthisis (2011) Nephrology (Carlton), 16 (5), pp. 495-501;
Zhou, B., Nelson, T.R., Kashtan, C., Identification of two alternatively spliced forms of human tubulointerstitial nephritis antigen (TIN-Ag) (2000) J Am Soc Nephrol, 11 (4), pp. 658-668;
Xie, P., Sun, L., Nayak, B., C/EBP-beta modulates transcription of tubulointerstitial nephritis antigen in obstructive uropathy (2009) J Am Soc Nephrol, 20 (4), pp. 807-819;
Yoshioka, K., Kleppel, M., Fish, A.J., Analysis of nephritogenic antigens in human glomerular basement membrane by two-dimensional gel electrophoresis (1985) J Immunol, 134, pp. 3831-3837;
Kashtan, C., Fish, A.J., Kleppel, M., Nephritogenic antigen determinants in epidermal and renal basement membranes of kindreds with Alport-type familial nephritis (1986) J Clin Invest, 78, pp. 1035-1044;
Hatanaka, Y., Yuzawa, Y., Nishikawa, K., Role of a rat membrane inhibitor of complement in anti-basement membrane antibody-induced renal injury (1995) Kidney Int, 48, pp. 1728-1737;
Ellis, D., Fisher, S.E., Smith, W.I., Jr., Familial occurrence of renal and intestinal disease associated with tissue autoantibodies (1982) Am J Dis Child, 136, pp. 323-326;
Hyun, J., Galen, M.A., Acute interstitial nephritis. A case characterized by increase in serum IgG, IgM, and IgE concentrations, eosinophilia, and IgE deposition in renal tubules (1981) Arch Intern Med, 141, pp. 679-681;
Tokumoto, M., Fukuda, K., Shinozaki, M., Acute interstitial nephritis with immune complex deposition and MHC class II antigen presentation along the tubular basement membrane (1999) Nephrol Dial Transplant, 14, pp. 2210-2215;
Takeda, S., Haratake, J., Kasai, T., IgG4-associated idiopathic tubulointerstitial nephritis complicating autoimmune pancreatitis (2004) Nephrol Dial Transplant, 19, pp. 474-476;
Markowitz, G.S., Fine, P.L., Kunis, C.L., Polyclonal immunoglobulin G deposition disease: a unique entity (1998) Am J Kidney Dis, 32, pp. 328-333;
Sarles, H., Sarles, J.C., Muratore, R., Chronic inflammatory sclerosis of the pancreas-an autonomous pancreatic disease (1961) Am J Dig Dis, 6, pp. 688-698;
Hamano, H., Kawa, S., Horiuchi, A., High serum IgG4 concentrations in patients with sclerosing pancreatitis (2001) N Engl J Med, 344 (10), pp. 732-738;
Hamano, H., Kawa, S., Ochi, Y., Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis (2002) Lancet, 359 (9315), pp. 1403-1404;
Uchida, K., Satoi, S., Miyoshi, H., Inflammatory pseudotumors of the pancreas and liver with infiltration of IgG4-positive plasma cells (2007) Intern Med, 46 (17), pp. 1409-1412;
Yamada, K., Kawano, M., Inoue, R., Clonal relationship between infiltrating immunoglobulin G4 (IgG4)-positive plasma cells in lacrimal glands and circulating IgG4-positive lymphocytes in Mikulicz's disease (2008) Clin Exp Immunol, 152 (3), pp. 432-439;
Taguchi, M., Aridome, G., Abe, S., Autoimmune pancreatitis with IgG4-positive plasma cell infiltration in salivary glands and biliary tract (2005) World J Gastroenterol, 11 (35), pp. 5577-5581;
Zen, Y., Kitagawa, S., Minato, H., IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung (2005) Hum Pathol, 36 (7), pp. 710-717;
Sprangers, B., Lioen, P., Meijers, B., The many faces of Merlin: IgG4-associated pulmonary-renal disease (2011) Chest, 140 (3), pp. 791-794;
Chetty, R., Serra, S., Gauchotte, G., Sclerosing nodular lesions of the gastrointestinal tract containing large numbers of IgG4 plasma cells (2011) Pathology, 43 (1), pp. 31-35;
Zen, Y., Kasahara, Y., Horita, K., Inflammatory pseudotumor of the breast in a patient with a high serum IgG4 level: Histologic similarity to sclerosing pancreatitis (2005) Am J Surg Pathol, 29 (2), pp. 275-278;
Lee, L.Y., Chen, T.C., Kuo, T.T., Simultaneous occurrence of IgG4-related chronic sclerosing dacryoadenitis and chronic sclerosing sialadenitis associated with lymph node involvement and Warthin's tumor (2011) Int J Surg Pathol, 19 (3), pp. 369-372;
Kamisawa, T., Nakajima, H., Egawa, N., IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy (2006) Pancreatology, 6 (1-2), pp. 132-137;
Zen, Y., Sawazaki, A., Miyayama, S., A case of retroperitoneal and mediastinal fibrosis exhibiting elevated levels of IgG4 in the absence of sclerosing pancreatitis (autoimmune pancreatitis) (2006) Hum Pathol, 37 (2), pp. 239-243;
Takahashi, H., Yamamoto, M., Suzuki, C., The birthday of a new syndrome: IgG4-related diseases constitute a clinical entity (2010) Autoimmun Rev, 9 (9), pp. 591-594;
Umehara, H., Okazaki, K., Masaki, Y., Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011 (2012) Mod Rheumatol, 22 (1), pp. 21-30;
Umehara, H., Okazaki, K., Masaki, Y., A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details (2012) Mod Rheumatol, 22, pp. 1-14;
Cornell, L.D., IgG4-related tubulointerstitial nephritis (2010) Kidney Int, 78 (10), pp. 951-953;
Otsuki, M., Chung, J.B., Okazaki, K., Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis (2008) J Gastroenterol, 43 (6), pp. 403-408;
Kawano, M., Saeki, T., Nakashima, H., Proposal for diagnostic criteria for IgG4-related kidney disease (2011) Clin Exp Nephrol, 15 (5), pp. 615-626;
Yamaguchi, Y., Kanetsuna, Y., Honda, K., Characteristic tubulointerstitial nephritis in IgG4-related disease (2012) Hum Pathol, 43 (4), pp. 536-549. , on behalf of the Japanese study group on IgG4-related nephropathy;
Houghton, D.C., Troxell, M.L., An abundance of IgG4+ plasma cells is not specific for IgG4-related tubulointerstitial nephritis (2011) Mod Pathol, 24 (11), pp. 1480-1487;
Fervenza, F.C., Downer, G., Beck, L.H., Jr., IgG4-related tubulointerstitial nephritis with membranous nephropathy (2011) Am J Kidney Dis, 58 (2), pp. 320-324;
Cravedi, P., Abbate, M., Gagliardini, E., Membranous nephropathy associated with IgG4-related disease (2011) Am J Kidney Dis, 58 (2), pp. 272-275;
Beck, L.H., Jr., Salant, D.J., Membranous nephropathy: Recent travels and new roads ahead (2010) Kidney Int, 77 (9), pp. 765-770;
Kearney, N., Podolak, J., Matsumura, L., Patterns of IgG subclass deposits in membranous glomerulonephritis in renal allografts (2011) Transplant Proc, 43 (10), pp. 3743-3746;
Divatia, M., Kim, S.A., Ro, J.Y., IgG4-related sclerosing disease, an emerging entity: A review of a multi-system disease (2012) Yonsei Med J, 53 (1), pp. 15-34;
Deshpande, V., Chicano, S., Finkelberg, D., Autoimmune pancreatitis: a systemic immune complex mediated disease (2006) Am J Surg Pathol, 30 (12), pp. 1537-1545;
Aalberse, R.C., Stapel, S.O., Schuurman, J., Immunoglobulin G4: An odd antibody (2009) Clin Exp Allergy, 39 (4), pp. 469-477;
Rispens, T., Ooijevaar-De Heer, P., Bende, O., Mechanism of immunoglobulin G4 Fab-arm exchange (2011) J Am Chem Soc, 133 (26), pp. 10302-10311;
Kountouras, J., Deretzi, G., Zavos, C., Association between Helicobacter pylori infection and acute inflammatory demyelinating polyradiculoneuropathy (2005) Eur J Neurol, 12 (2), pp. 139-143;
Guarneri, F., Guarneri, C., Benvenga, S., Helicobacter pylori and autoimmune pancreatitis: Role of carbonic anhydrase via molecular mimicry? (2005) J Cell Mol Med, 9 (3), pp. 741-744;
Frulloni, L., Lunardi, C., Simone, R., Identification of a novel antibody associated with autoimmune pancreatitis (2009) N Engl J Med, 361 (22), pp. 2135-2142;
Okazaki, K., Uchida, K., Fukui, T., Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis (2008) J Gastroenterol, 43 (6), pp. 409-418;
Yamamoto, M., Naishiro, Y., Suzuki, C., Proteomics analysis in 28 patients with systemic IgG4-related plasmacytic syndrome (2010) Rheumatol Int, 30 (4), pp. 565-568;
Akitake, R., Watanabe, T., Zaima, C., Possible involvement of T helper type 2 responses to Toll-like receptor ligands in IgG4-related sclerosing disease (2010) Gut, 59 (4), pp. 542-545;
Kawa, S., Ota, M., Yoshizawa, K., HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population (2002) Gastroenterology, 122 (5), pp. 1264-1269;
Park do, H., Kim, M.H., Oh, H.B., Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis (2008) Gastroenterology, 134 (2), pp. 440-446;
Kim, T.Y., Park, K.S., Choi, J.S., Comparative clinical manifestations of IgG4- related and IgG4-negative primary tubulointerstitial nephritis (2011) Clin Nephrol, 76 (6), pp. 440-446;
Brentjens, J.R., Sepulveda, M., Baliah, T., Interstitial immune complex nephritis in patients with systemic lupus erythematosus (1975) Kidney Int, 7, pp. 342-350;
Park, M.H., D'Agati, V., Appel, G.B., Tubulointerstitial disease in lupus nephritis: Relationship to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis (1986) Nephron, 44, pp. 309-319;
Schwartz, M.M., Fennell, J.S., Lewis, E.J., Pathologic changes in the renal tubule in systemic lupus erythematosus (1982) Hum Pathol, 13, pp. 534-547;
Biesecker, G., Katz, S., Koffler, D., Renal localization of the membrane attack complex in systemic lupus erythematosus nephritis (1981) J Exp Med, 154, pp. 1779-1794;
Chang, A., Henderson, S.G., Brandt, D., In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis (2011) J Immunol, 186 (3), pp. 1849-1860;
Pijpe, J., Vissink, A., Van der Wal, J.E., Interstitial nephritis with infiltration of IgG-kappa positive plasma cells in a patient with Sjögren's syndrome (2004) Rheumatology (Oxford), 43, pp. 108-110;
Wisnieski, J.J., Baer, A.N., Christensen, J., Hypocomplementemic urticarial vasculitis syndrome. Clinical and serologic findings in 18 patients (1995) Medicine (Baltimore), 74 (1), pp. 24-41;
Buck, A., Christensen, J., McCarty, M., Hypocomplementemic urticarial vasculitis syndrome: A case report and literature review (2012) J Clin Aesthet Dermatol, 5 (1), pp. 36-46;
Matsutani, H., Mizusawa, J., Shimoda, M., Severe glomerulonephritis and tubulo-interstitial nephritis accompanied with urticaria and vasculitis (1990) Child Nephrol Urol, 10 (4), pp. 214-217;
Toprak, O., Cirit, M., Uzunel, H., Hypocomplementaemic urticarial vasculitis syndrome and acute renal failure with cryoglobulin (-) hepatitis C infection (2004) Nephrol Dial Transplant, 19 (10), pp. 2680-2682;
Wakamatsu, R., Watanabe, H., Suzuki, K., Hypocomplementemic urticarial vasculitis syndrome is associated with high levels of serum IgG4: A clinical manifestation that mimics IgG4-related disease (2011) Intern Med, 50 (10), pp. 1109-1012;
Chang, A., Peutz-Kootstra, C.J., Kowalewska, J., Giant cell tubulitis with tubular basement membrane immune deposits: A report of two cases after cardiac valve replacement surgery (2006) Clin J Am Soc Nephrol, 1 (5), pp. 920-924;
Hodgin, J.B., Whelan, J., Markowitz, G.S., Giant cell tubulitis with immune complex deposits in a patient with lupus nephritis (2009) Am J Kidney Dis, 53 (3), pp. 513-517;
Lee, L., Sevastos, J., Rainer, S., Giant cell tubulitis and tubular basement membrane immune deposits (2011) Pathology, 43 (4), pp. 383-386;
Ohsawa, I., Ohi, H., Fujita, T., Glomerular and extraglomerular immune complex deposits in a bone marrow transplant recipient (2000) Am J Kidney Dis, 36, p. E3;
Adeyi, O.A., Sethi, S., Rennke, H.G., Fibrillary glomerulonephritis: A report of 2 cases with extensive glomerular and tubular deposits (2001) Hum Pathol, 32, pp. 660-663;
Hoyer, J.R., Tubulointerstitial immune complex nephritis in rats immunized with Tamm-Horsfall protein (1980) Kidney Int, 17, pp. 284-292;
Fasth, A., Hoyer, J.R., Seiler, M.W., Renal tubular immune complex formation in mice immunized with Tamm-Horsfall protein (1986) Am J Pathol, 125, pp. 555-562;
Seiler, M.W., Hoyer, J.R., Ultrastructural studies of tubulointerstitial immune complex nephritis in rats immunized with Tamm-Horsfall protein (1981) Lab Invest, 45, pp. 321-327;
Fasth, A.L., Hoyer, J.R., Seiler, M.W., Extratubular Tamm-Horsfall protein deposits induced by ureteral obstruction in mice (1988) Clin Immunol Immunopathol, 47, pp. 47-61;
Benkovic, J., Jelakovic, B., Cikes, N., Antibodies to Tamm-Horsfall protein in patients with acute pyelonephritis (1994) Eur J Clin Chem Clin Biochem, 32, pp. 337-340;
Fasth, A., Ahlstedt, S., Hanson, L.A., Cross-reactions between the Tamm-Horsfall glycoprotein and Escherichia coli (1980) Int Arch Allergy Appl Immunol, 63, pp. 303-311;
Faaber, P., Rijke, T.P., van de Putte, L.B., Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycosaminoglycan in glomerular basement membranes (1986) J Clin Invest, 77, pp. 1824-1830;
Thomas, D.B., Davies, M., Williams, J.D., Tamm-Horsfall protein: An aetiological agent in tubulointerstitial disease (1993) Exp Nephrol, 1, pp. 281-284;
El-Achkar, T.M., Workup, X.R., Uromodulin in kidney injury: An instigator, bystander, or protector? (2012) Am J Kidney Dis, 59 (3), pp. 452-461. , [Epub 2012 Jan 23];
Koffler, D., Schur, P.H., Kunkel, H.G., Immunological studies concerning the nephritis of systemic lupus erythematosus (1967) J Exp Med, 126, pp. 607-624;
Tax, W.J., Kramers, C., van Bruggen, M.C., Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus (1995) Kidney Int, 48, pp. 666-673;
Nath, K.A., Hostetter, M.K., Hostetter, T.H., Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3 (1985) J Clin Invest, 76, pp. 667-675;
Dobrin, R.S., Vernier, R.L., Fish, A.L., Acute eosinophilic interstitial nephritis and renal failure with bone marrow-lymph node granulomas and anterior uveitis. A new syndrome (1975) Am J Med, 59, pp. 325-333;
Howarth, L., Gilbert, R.D., Bass, P., Tubulointerstitial nephritis and uveitis in monozygotic twin boys (2004) Pediatr Nephrol, 19, pp. 917-919;
Mackensen, F., Billing, H., Tubulointerstitial nephritis and uveitis syndrome (2009) Curr Opin Ophthalmol, 20 (6), pp. 525-531;
Thomassen, V.H., Ring, T., Thaarup, J., Tubulointerstitial nephritis and uveitis (TINU) syndrome: A case report and review of the literature (2009) Acta Ophthalmol, 87 (6), pp. 676-679;
Liakopoulos, V., Ioannidis, I., Zengos, N., Tubulointerstitial nephritis and uveitis (TINU) syndrome in a 52-year-old female: A case report and review of the literature (2006) Ren Fail, 28 (4), pp. 355-359;
Weinstein, O., Tovbin, D., Rogachev, B., Clinical manifestations of adult tubulointerstitial nephritis and uveitis (TINU) syndrome (2010) Int Ophthalmol, 30 (5), pp. 621-628;
Yasuda, K., Sasaki, Kfalsefalsefalsefalse2017-01-02T11:20:56.000+00002016-10-04T10:20:56.000+0000812020true1592true10002English
/api/language/10002
AngolLanguagetrue2falsetrue10233true10017
/api/country/10017
Countrytrue13
/api/city/10233
Citytrue354true11292882
/api/publicationidentifier/11292882
https://www.worldcat.org/search?q=isbn%3A97814698875559781469887555PublicationIdentifierfalsetrue11579586
/api/publicationidentifier/11579586
https://www.worldcat.org/search?q=isbn%3A97814511441169781451144116PublicationIdentifierfalse
/api/publication/30238560
truetrue2323
/api/publicationtype/23
PublicationType3true23BookHeptinstall's Pathology of the Kidneyfalsefalse30238560falsetruefalsetruetrue10000201Monographtrue2323
/api/publicationtype/23
PublicationType3true23Book
/api/subtype/10000201
SzakkönyvSubType337true10000201trueBook2014true1
/api/category/1
Categorytrue1falseLanguage10002
/api/language/10002
AngolEnglishtrue2truePersonAuthorship59988217
/api/authorship/59988217
10.0truefalseBrodskySVtruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalse123317951truePersonAuthorship59988218
/api/authorship/59988218
20.0falsetrueNadasdyTtruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalse123317950truePublicationIdentifier11580541
/api/publicationidentifier/11580541
IDENTICAL84974808219http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-84974808219false13421943true
/api/publication/26107062
<div class="BookChapter Publication short-list"> <div class="authors"> <span class="author-name" > Brodsky, SV </span> <span class="author-type"> </span> ; <span class="author-name" > Nadasdy, T </span> <span class="author-type"> </span> </div ><div class="title"><a href="/gui2/?mode=browse¶ms=publication;26107062" mtid="26107062" target="_blank">Acute and chronic tubulointerstitial nephritis</a></div> <div class="InBook">In: J., Charles Jennette; Vivette, D. D'Agati; Jean, L. Olson; Fred, G. Silva (szerk.) <span class="booktitle"><a href="/gui2/?mode=browse¶ms=publication;30238560" target="_blank">Heptinstall's Pathology of the Kidney </a></span > </div><div class="pub-info"> <span class="publishedAt">Philadelphia (PA), Amerikai Egyesült Államok : <span class="publisher">Wolters Kluwer Health</span> <span class="year">(2014)</span> <span class="pageLength">1,592 p.</span> <span class="page"> </span> </div> <div class="pub-end"><div class="identifier-list"> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="84974808219" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-84974808219"> Scopus </a> </span> </span> </div> <div class="short-pub-prop-list"> <span class="short-pub-mtid"> Közlemény:26107062 </span> <span class="status-holder"><span class="status-data status-APPROVED"> Nyilvános </span></span> <span class="pub-core"> Idéző </span> <span class="pub-type">Könyvrészlet (Könyvfejezet ) </span> <!-- && !record.category.scientific --> <span class="pub-category">Tudományos</span> | <span class="pub-error"> Hibás </span> </div> </div> </div><div class="BookChapter Publication long-list"> <div class="authors"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" >Brodsky SV </span> ; <span class="author-name" >Nadasdy T </span> </div> </div> <div class="title"><a href="/gui2/?mode=browse¶ms=publication;26107062" target="_blank">Acute and chronic tubulointerstitial nephritis</a></div> <div class="InBook"><div class="chapter-in">In:</div> <div class="authors"> <div class="autype autype-1"> <span class="author-name" >J. Charles Jennette </span> ; <span class="author-name" >Vivette D. D'Agati </span> ; <span class="author-name" >Jean L. Olson </span> ; <span class="author-name" >Fred G. Silva </span> (szerk.) </div> </div> <div class="booktitle"><a href="/gui2/?mode=browse¶ms=publication;30238560" target="_blank">Heptinstall's Pathology of the Kidney </a></div> <span class="publishedAt">Philadelphia (PA): <span class="publishers">Wolters Kluwer Health</span>, <span class="page"> </span> <span class="year">(2014)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="84974808219" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-84974808219"> Scopus </a> </span> </span> <span class="bookchapter-ids">Befoglaló link(ek):</span> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <span class="isbnOrIssn"> ISBN: </span> <a style="color:black" title="9781469887555" target="_blank" href="https://www.worldcat.org/search?q=isbn%3A9781469887555"> 9781469887555 </a> </span> <span class="id identifier oa_none" title="none"> <span class="isbnOrIssn"> ISBN: </span> <a style="color:black" title="9781451144116" target="_blank" href="https://www.worldcat.org/search?q=isbn%3A9781451144116"> 9781451144116 </a> </span> </span> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;26107062&sort=publishedYear,desc&sort=title"> Idézett közlemények száma: 2 </a> </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 26107062</span> | <span class="status-data status-APPROVED"> Nyilvános </span> <span class="long-book-mtid">Befoglaló: 30238560</span> <span class="oldId">Régi azonosító: 16107062</span> | Idéző | <span class="type-subtype">Könyvrészlet ( Könyvfejezet ) </span> | <span class="pub-category">Tudományos</span> | <span class="errorStatus"> Hibás </span> | <span class="publication-sourceOfData">Scopus-RIS</span> </div> <div class="lastModified">Utolsó módosítás: 2021.03.02. 15:14 Pécsi Éva (MTMT Közp 3, admin) </div> </div> </div>